NEW YORK, Aug. 21, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alamos Gold Inc.
(NYSE:AGI), Nomad Foods Limited (NYSE:NOMD), MyoKardia, Inc. (NASDAQ:MYOK), Mesoblast Limited (NASDAQ:MESO), Core-Mark Holding
Company, Inc. (NASDAQ:CORE), and Jounce Therapeutics, Inc. (NASDAQ:JNCE), including updated fundamental summaries, consolidated
fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
AGI DOWNLOAD: http://Fundamental-Markets.com/register/?so=AGI
NOMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=NOMD
MYOK DOWNLOAD: http://Fundamental-Markets.com/register/?so=MYOK
MESO DOWNLOAD: http://Fundamental-Markets.com/register/?so=MESO
CORE DOWNLOAD: http://Fundamental-Markets.com/register/?so=CORE
JNCE DOWNLOAD: http://Fundamental-Markets.com/register/?so=JNCE
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Alamos Gold Inc. (NYSE:AGI), Nomad Foods Limited (NYSE:NOMD), MyoKardia, Inc. (NASDAQ:MYOK), Mesoblast Limited (NASDAQ:MESO),
Core-Mark Holding Company, Inc. (NASDAQ:CORE), and Jounce Therapeutics, Inc. (NASDAQ:JNCE) on a fundamental level and outlines the
overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion,
and overall direction going forward. Several excerpts from the recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed August 17th,
2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ALAMOS GOLD INC. (AGI) REPORT OVERVIEW
Alamos Gold's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Alamos Gold reported revenue of $168.90MM vs
$131.30MM (up 28.64%) and basic earnings per share -$0.02 vs $0.01. For the twelve months ended December 31st, 2017 vs December
31st, 2016, Alamos Gold reported revenue of $542.80MM vs $482.20MM (up 12.57%) and basic earnings per share $0.09 vs -$0.07. Alamos
Gold is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018.
The reported EPS for the same quarter last year was $0.05. The estimated EPS forecast for the next fiscal year is $0.21 and is
expected to report on February 28th, 2019.
To read the full Alamos Gold Inc. (AGI) report, download it here: http://Fundamental-Markets.com/register/?so=AGI
-----------------------------------------
NOMAD FOODS LIMITED (NOMD) REPORT OVERVIEW
Nomad Foods' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Nomad Foods reported revenue of $582.23MM vs
$503.86MM (up 15.55%) and basic earnings per share $0.21 vs $0.12 (up 77.44%). For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Nomad Foods reported revenue of $2,211.55MM vs $2,133.19MM (up 3.67%) and basic earnings per share $0.88 vs
$0.22 (up 298.91%). Nomad Foods is expected to report earnings on November 27th, 2018. The report will be for the fiscal period
ending September 30th, 2018. The reported EPS for the same quarter last year was $0.29. The estimated EPS forecast for the next
fiscal year is $1.50 and is expected to report on March 28th, 2019.
To read the full Nomad Foods Limited (NOMD) report, download it here: http://Fundamental-Markets.com/register/?so=NOMD
-----------------------------------------
MYOKARDIA, INC. (MYOK) REPORT OVERVIEW
MyoKardia's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, MyoKardia reported revenue of $6.64MM vs $3.00MM
(up 121.23%) and basic earnings per share -$0.49 vs -$0.50. For the twelve months ended December 31st, 2017 vs December 31st, 2016,
MyoKardia reported revenue of $22.50MM vs $39.20MM (down 42.60%) and basic earnings per share -$1.40 vs -$0.48. MyoKardia is
expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The
reported EPS for the same quarter last year was -$0.42. The estimated EPS forecast for the next fiscal year is -$3.22 and is
expected to report on March 14th, 2019.
To read the full MyoKardia, Inc. (MYOK) report, download it here: http://Fundamental-Markets.com/register/?so=MYOK
-----------------------------------------
MESOBLAST LIMITED (MESO) REPORT OVERVIEW
Mesoblast's Recent Financial Performance
For the three months ended March 31st, 2018 vs March 31st, 2017, Mesoblast reported revenue of $1.07MM vs
$0.90MM (up 18.76%) and basic earnings per share -$0.22 vs -$0.12. For the twelve months ended June 30th, 2017 vs June 30th, 2016,
Mesoblast reported revenue of $2.41MM vs $42.55MM (down 94.33%) and basic earnings per share -$0.97 vs -$0.06. Mesoblast is
expected to report earnings on September 4th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported
EPS for the same quarter last year was -$0.32. The estimated EPS forecast for the next fiscal year is -$0.93 and is expected to
report on September 4th, 2018.
To read the full Mesoblast Limited (MESO) report, download it here: http://Fundamental-Markets.com/register/?so=MESO
-----------------------------------------
CORE-MARK HOLDING COMPANY, INC. (CORE) REPORT OVERVIEW
Core-Mark Holding's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Core-Mark Holding reported revenue of $4,226.50MM
vs $3,800.70MM (up 11.20%) and basic earnings per share $0.24 vs $0.15 (up 60.00%). For the twelve months ended December 31st, 2017
vs December 31st, 2016, Core-Mark Holding reported revenue of $15,687.60MM vs $14,529.40MM (up 7.97%) and basic earnings per share
$0.72 vs $1.17 (down 38.46%). Core-Mark Holding is expected to report earnings on November 6th, 2018. The report will be for the
fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast
for the next fiscal year is $1.39 and is expected to report on March 7th, 2019.
To read the full Core-Mark Holding Company, Inc. (CORE) report, download it here: http://Fundamental-Markets.com/register/?so=CORE
-----------------------------------------
JOUNCE THERAPEUTICS, INC. (JNCE) REPORT OVERVIEW
Jounce Therapeutics' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Jounce Therapeutics reported revenue of $19.38MM
vs $20.29MM (down 4.49%) and basic earnings per share -$0.14 vs -$0.11. For the twelve months ended December 31st, 2017 vs December
31st, 2016, Jounce Therapeutics reported revenue of $71.64MM vs $37.20MM (up 92.61%) and basic earnings per share -$0.57 vs
-$11.00. Jounce Therapeutics is expected to report earnings on November 12th, 2018. The report will be for the fiscal period ending
September 30th, 2018. The reported EPS for the same quarter last year was -$0.13. The estimated EPS forecast for the next fiscal
year is -$1.22 and is expected to report on March 14th, 2019.
To read the full Jounce Therapeutics, Inc. (JNCE) report, download it here: http://Fundamental-Markets.com/register/?so=JNCE
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
